Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Creams: SOP for Deviations Handling in Cream Production – V 2.0

Posted on By

Creams: SOP for Deviations Handling in Cream Production – V 2.0

Standard Operating Procedure for Deviations Handling in Cream Production

Department Creams
SOP No. SOP/CRM/183/2025
Supersedes SOP/CRM/183/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to define the process for handling deviations during cream production to ensure that any deviations from the approved process are identified, documented, investigated, and resolved to maintain product quality and compliance with GMP guidelines.

2. Scope

This SOP applies to all deviations that occur during the cream production process, including those related to raw materials, equipment, procedures, and quality control. It covers the identification, documentation, investigation, and resolution of deviations.

3. Responsibilities

  • Production Team: Responsible for identifying and reporting any deviations from the approved process during cream production. They must document the deviation in the Deviation Report (Annexure-1) and immediately notify the QC and QA teams.
  • Quality Control (QC) Team: Responsible for reviewing the deviation report, conducting investigations into the causes of deviations, and assessing their impact on product quality. QC must also assist in implementing corrective actions.
  • Quality Assurance (QA) Team: Responsible for overseeing the deviation handling process, ensuring that all deviations are
thoroughly investigated, documented, and resolved. QA ensures that corrective and preventive actions (CAPA) are implemented and that the final resolution complies with regulatory requirements.
  • Management Team: Responsible for ensuring that proper resources are available to address deviations and that corrective actions are effectively implemented.
  • 4. Accountability

    The Production Manager is accountable for identifying and reporting deviations during production. The QC Manager is responsible for investigating the deviations and ensuring that any required testing or analysis is completed. The QA Manager is responsible for ensuring compliance with this SOP and for approving corrective actions.

    5. Procedure

    5.1 Identifying and Reporting Deviations

    1. During the production process, if any deviation from the approved procedures, specifications, or standards occurs, the production team must immediately report it to the QC and QA teams.
    2. Deviations can include, but are not limited to, incorrect raw materials, improper processing parameters (e.g., temperature, pH, mixing time), equipment malfunction, or out-of-specification test results.
    3. Document the deviation in the Deviation Report (Annexure-1), including the nature of the deviation, the affected batch, time of occurrence, and any immediate corrective actions taken by the production team.

    5.2 Documenting Deviations

    1. The Deviation Report (Annexure-1) must include the following details:
      • Batch number
      • Deviation description
      • Date and time of occurrence
      • Initial corrective actions taken
      • Potential impact on product quality
      • Investigating team (QC/QA)
    2. The completed Deviation Report must be submitted to the QA team for further investigation and approval.

    5.3 Investigating Deviations

    1. The QA team is responsible for conducting a thorough investigation into the deviation. The investigation should address the following:
      • Root cause analysis to identify why the deviation occurred (e.g., human error, equipment failure, raw material issue).
      • Assessment of the impact of the deviation on product quality, safety, and compliance.
      • Evaluation of the risk to other batches or future production runs.
    2. The QC team will support the investigation by conducting any required testing or analysis to assess the quality of the affected batch, such as retesting raw materials or rechecking product specifications.
    3. If the cause of the deviation cannot be immediately identified, a more detailed investigation may be required, including the review of historical data, equipment maintenance logs, and personnel training records.

    5.4 Implementing Corrective Actions

    1. Based on the findings of the investigation, the QA team will determine the appropriate corrective actions to prevent recurrence of the deviation. These actions may include, but are not limited to:
      • Adjusting production procedures or equipment settings
      • Replacing or recalibrating faulty equipment
      • Re-training production staff on the correct procedures
      • Changing raw material suppliers if the deviation is related to material quality
    2. Corrective actions should be implemented immediately and must be documented in the Deviation Report.
    3. The QA team must ensure that all corrective actions are verified for effectiveness and that the batch is re-evaluated to confirm that the deviation has been resolved.

    5.5 Preventive Actions

    1. After addressing the immediate deviation, the QA team will evaluate whether preventive actions are required to reduce the likelihood of similar deviations occurring in the future.
    2. Preventive actions can include process changes, equipment upgrades, or enhanced quality control checks. These actions should be documented in the Corrective and Preventive Action (CAPA) log (Annexure-2).
    3. Once preventive actions are implemented, they must be monitored to ensure their effectiveness and be periodically reviewed during internal audits or management reviews.

    5.6 Closing the Deviation Report

    1. Once corrective and preventive actions have been implemented, and the batch is verified to be in compliance, the deviation report can be closed.
    2. The final report, including investigation findings, corrective actions, preventive actions, and any other relevant information, must be reviewed and approved by the QA Manager.
    3. The completed Deviation Report and associated documentation must be filed and stored in accordance with GMP guidelines for future reference and audit purposes.

    5.7 Documentation and Record-Keeping

    1. Ensure that all deviation-related documentation, including the Deviation Report, CAPA log, investigation reports, and corrective action records, are stored for a minimum of two years or as required by regulatory guidelines.
    2. All deviation records should be easily accessible for internal audits, external inspections, and regulatory reviews.
    3. Ensure that all records are signed and dated by the responsible parties to maintain accountability and traceability.

    6. Abbreviations

    • GMP: Good Manufacturing Practices
    • QC: Quality Control
    • QA: Quality Assurance
    • PPE: Personal Protective Equipment
    • CAPA: Corrective and Preventive Action

    7. Documents

    1. Annexure-1: Deviation Report
    2. Annexure-2: CAPA Log

    8. References

    • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
    • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • FDA Guidance for Industry: Deviations Handling in Pharmaceutical Manufacturing

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Deviation Report

    Batch Number Deviation Description Corrective Action Taken Resolved By Resolution Date
    12345 Deviation in pH during mixing Adjusted mixing process, re-tested pH QA Head 22/01/2026

    Annexure-2: CAPA Log

    Corrective Action Description Preventive Action Description Implementation Date Responsible Person
    Recalibrated mixing equipment Scheduled regular equipment calibration 23/01/2026 Maintenance Supervisor

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/03/2024 1.0 Initial Version New SOP Creation QA Head
    01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
    See also  Creams: SOP for Preventing Contamination during Material Dispensing - V 2.0
    Creams V 2.0 Tags:Batch record documentation for creams, Change control procedures for cream manufacturing, Cleaning and sanitization SOPs in creams production, Complaint handling SOPs in creams production, Continuous improvement SOPs for cream manufacturing, Cream manufacturing process guidelines, Creams production documentation practices, Deviation handling SOPs in creams production, Employee training SOPs in creams manufacturing, Environmental monitoring SOPs in creams manufacturing, Equipment calibration SOPs for cream manufacturing, GMP compliance in creams production, Internal audit procedures in creams production, Packaging and labeling SOPs for creams, Pharmaceutical SOPs, Product quality review procedures for creams, Product release criteria SOPs for creams, Quality control SOPs for creams, ream manufacturing SOP, Regulatory requirements for cream production SOPs, Risk management SOPs in creams manufacturing, Stability testing SOPs for cream products, Standard operating procedures for skincare products, Supplier qualification SOPs for cream ingredients, Validation protocols for cream production processes

    Post navigation

    Previous Post: Aerosol: SOP for Addressing Non-Conformance in Aerosol Manufacturing – V 2.0
    Next Post: Sterile Injectable Manufacturing: SOP for Cleaning of Injectable Filling Machines – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version